With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, HIV remains a major global epidemic. While anti-retroviral therapy (ART) can control the infection, dormant HIV-infected ...
Jun 23, 2022
0
56
Many male couples in the U.S. seem to be underestimating the effectiveness of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, and educating partners together could improve the number of male couples who decide to ...
Jun 17, 2022
0
6
During the early days of the COVID-19 pandemic, many people turned to their pets to help them feel less lonely and isolated. Researchers at the University of California, Davis, wanted to learn what role pets played in helping ...
Jun 15, 2022
0
55
A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than ...
Jun 15, 2022
0
28
The province of Saskatchewan leads the country in preventable, opportunistic illnesses enabled by poverty. With new changes to income support programs and increased housing instability, things are getting worse.
Jun 15, 2022
0
11
The South African Health Products Regulatory Authority (SAHPRA) has approved a sweet-tasting, heat-stable, "4-in-1" fixed-dose combination of four antiretroviral (ARV) treatments composed of abacavir, lamivudine, lopinavir, ...
Jun 14, 2022
1
7
A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for patients with HIV. The study examined the engineering of type B white blood ...
Jun 13, 2022
0
833
Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), ...
Jun 1, 2022
0
64
While multiple effective COVID-19 vaccines were developed with astonishing speed, it has been more than 40 years since University of Rochester alumnus Michael Gottlieb, M.D., first described the disease that became known ...
May 27, 2022
0
13
New research from the University at Buffalo reveals valuable information about the ways that host cells work to block entry of SARS-CoV-2 and, in turn, how the virus strikes back.
May 26, 2022
0
58
